Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study-Reference-Cited by-同舟云学术

Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study

Published:2020-10 Issue:1 Volume:159 Page:17-22
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Erickson Britt K.,Najjar Omar,Damast Shari,Blakaj Adriana,Tymon-Rosario Joan,Shahi Maryam,Santin Alessandro,Klein Molly,Dolan Michelle,Cimino-Mathews Ashley,Buza Natalia,Ferriss J. Stuart,Stone Rebecca L.,Khalifa Mahmoud,Fader Amanda N.

Funder

BKE

National Institute of Child Health and Human Development

National Institutes of Health

ADS

NIH

Deborah Bunn Alley Foundation

Tina Brozman Foundation

Guido Berlucchi Foundation

Stolz Family Fund

Kosegarten Family Fund

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference27 articles.

1. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers;Hamilton;Br. J. Cancer,2006

2. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma;Fader;Cancer.,2009

3. Stage II uterine papillary serous carcinoma: carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes;Fader;Gynecol. Oncol.,2009

4. Outcomes in surgical stage I uterine papillary serous carcinoma;Havrilesky;Gynecol. Oncol.,2007

5. Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes--a systematic review;Chua;Int. J. Cancer,2012

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of antigenicity between frozen section vs non−frozen section tissue blocks: An immunohistochemical study of antibodies commonly used in gynecologic pathology;American Journal of Clinical Pathology;2024-08-07

2. Human epidermal growth factor 2 (HER2) amplification in uterine serous carcinoma: an analysis of prognosis and immune microenvironment;Virchows Archiv;2024-07-29

3. Use of angiotensin‑converting enzyme inhibitors in gynecological cancers: Pathways and mechanisms involved (Review);World Academy of Sciences Journal;2024-07-08

4. Consenso colombiano para el diagnóstico molecular del cáncer de endometrio;Revista Colombiana de Obstetricia y Ginecología;2024-06-17

5. Human epidermal growth factor receptor-2 (HER2) expression in FIGO3 high-grade endometrial endometrioid carcinoma: Clinicopathologic characteristics and future directions;Gynecologic Oncology;2024-06